                               SEQUENCE LISTING

<110> GEORGIA TECH RESEARCH CORPORATION
      MAPP BIOPHARMACEUTICAL, INC.
 
<120> MRNA-ENCODED ANTIBODIES FOR CONTRACEPTION

<130> 064489.083PCT

<140> PCT/US2020/057713
<141> 2020-10-28

<150> 62/926,771
<151> 2019-10-28

<160> 10    

<170> PatentIn version 3.5

<210> 1
<211> 57
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 1
atgggctggt cctgcatcat cctgttcctg gtggcaaccg caacaggagt gcacagc          57


<210> 2
<211> 1365
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 2
caggtgcagc tgcagcagtg gggagcagga ctgctgaagc cttctgagac cctgagcctg       60

acatgtgccg tgtatggcgg cagcttttcc ggctactatt ggtcctggat caggcagcca      120

cctggcaagg gactggagtg gatcggcgag atcaaccact ctggcagcac caactacaat      180

ccctctctgc ggagcagagt gaccatctcc gtggacacat ctaagaatca gttctctctg      240

aagctgcgca gcgtgaccgc agcagataca gccgtgtact attgcgccag gggctttatg      300

gtgcgcggca tcatgtggaa ctactattac atggacgtgt ggggcaaggg caccacagtg      360

accgtgtccc catctgccag cacaaaggga ccaagcgtgt tccctctggc accaagctcc      420

aagtccacct ctggaggaac agccgccctg ggctgtctgg tgaaggatta tttccctgag      480

ccagtgaccg tgtcctggaa ctctggcgcc ctgacctccg gagtgcacac atttccagcc      540

gtgctgcagt ctagcggcct gtatagcctg tcctctgtgg tgaccgtgcc cagctcctct      600

ctgggcaccc agacatacat ctgcaacgtg aatcacaagc caagcaatac aaaggtggac      660

aagcgggtgg agcccaagtc ctgtgataag acccacacat gcccaccatg tccagcacct      720

gagctgctgg gaggaccaag cgtgttcctg tttcctccaa agcctaagga caccctgatg      780

atctctagaa cccccgaggt gacatgcgtg gtggtggacg tgagccacga ggatcctgag      840

gtgaagttca actggtacgt ggatggcgtg gaggtgcaca atgccaagac caagccccgg      900

gaggagcagt ataactccac ctacagagtg gtgtctgtgc tgacagtgct gcaccaggac      960

tggctgaacg gcaaggagta caagtgcaag gtgtccaata aggccctgcc agcccccatc     1020

gagaagacca tctctaaggc aaagggacag ccaagggagc ctcaggtgta tacactgccc     1080

ccttcccgcg acgagctgac caagaaccag gtgtctctga catgtctggt gaagggcttt     1140

tacccttctg atatcgccgt ggagtgggag agcaatggcc agccagagaa caattataag     1200

accacaccac ccgtgctgga cagcgatggc tccttctttc tgtacagcaa gctgaccgtg     1260

gataagtccc ggtggcagca gggcaacgtg ttcagctgct ccgtgatgca cgaggccctg     1320

cacaatcact acacccagaa gtctctgagc ctgtcccctg gcaag                     1365


<210> 3
<211> 123
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 3
cacgagacca caccaaataa gggcagcggc accacatccg gcaccacaag actgctgagc       60

ggccacacct gttttaccct gacaggcctg ctgggcaccc tggtgacaat gggcctgctg      120

aca                                                                    123


<210> 4
<211> 57
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 4
atggcctgga cccctctgtg gctgacactg tttaccctgt gcatcggctc tgtggtg          57


<210> 5
<211> 642
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 5
agctccgagc tgacacagga cccagtggtg agcgtggccc tgggacagac agtgcggatc       60

acctgtcagg gcgattctct gagaacctac cacgccagct ggtatcagca gaagccaagg      120

caggcccccg tgctggtcat ctacgacgag aacaataggc cttccggcat cccagatcgc      180

ttctccggct ctacaagcgg caacaccgcc tctctgacaa tcaccggagc acaggcagag      240

gacgaggcag attactattg caactcccgg gactctagcg gcaatagact ggtgttcgga      300

ggaggaacaa agctgaccgt gctgggacag ccaaaggcag caccttccgt gaccctgttt      360

ccaccttcct ctgaggagct gcaggccaat aaggccaccc tggtgtgcct gatcagcgac      420

ttctacccag gagcagtgac agtggcatgg aaggccgata gctccccagt gaaggccggc      480

gtggagacca caacccccag caagcagtcc aacaataagt acgccgcctc tagctatctg      540

tccctgaccc ccgagcagtg gaagtctcac agatcctatt cttgccaggt gacacacgag      600

ggcagcacag tggagaagac cgtggcccct acagagtgtt cc                         642


<210> 6
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 6
Met Gly Trp Ser Cys Ile Ile Leu Phe Leu Val Ala Thr Ala Thr Gly 
1               5                   10                  15      


Val His Ser 
            


<210> 7
<211> 455
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 7
Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Arg 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Phe Met Val Arg Gly Ile Met Trp Asn Tyr Tyr Tyr Met Asp 
            100                 105                 110         


Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Pro Ser Ala Ser Thr 
        115                 120                 125             


Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser 
    130                 135                 140                 


Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu 
145                 150                 155                 160 


Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His 
                165                 170                 175     


Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser 
            180                 185                 190         


Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys 
        195                 200                 205             


Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu 
    210                 215                 220                 


Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro 
225                 230                 235                 240 


Glu Leu Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys 
                245                 250                 255     


Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val 
            260                 265                 270         


Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp 
        275                 280                 285             


Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr 
    290                 295                 300                 


Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp 
305                 310                 315                 320 


Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu 
                325                 330                 335     


Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg 
            340                 345                 350         


Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu Leu Thr Lys 
        355                 360                 365             


Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp 
    370                 375                 380                 


Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys 
385                 390                 395                 400 


Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser 
                405                 410                 415     


Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser 
            420                 425                 430         


Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser 
        435                 440                 445             


Leu Ser Leu Ser Pro Gly Lys 
    450                 455 


<210> 8
<211> 41
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 8
His Glu Thr Thr Pro Asn Lys Gly Ser Gly Thr Thr Ser Gly Thr Thr 
1               5                   10                  15      


Arg Leu Leu Ser Gly His Thr Cys Phe Thr Leu Thr Gly Leu Leu Gly 
            20                  25                  30          


Thr Leu Val Thr Met Gly Leu Leu Thr 
        35                  40      


<210> 9
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 9
Met Ala Trp Thr Pro Leu Trp Leu Thr Leu Phe Thr Leu Cys Ile Gly 
1               5                   10                  15      


Ser Val Val 
            


<210> 10
<211> 214
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 10
Ser Ser Glu Leu Thr Gln Asp Pro Val Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Thr Tyr His Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Arg Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Asp Glu Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Thr Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Asn Arg 
                85                  90                  95      


Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Gln Pro Lys 
            100                 105                 110         


Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser Glu Glu Leu Gln 
        115                 120                 125             


Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp Phe Tyr Pro Gly 
    130                 135                 140                 


Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro Val Lys Ala Gly 
145                 150                 155                 160 


Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn Lys Tyr Ala Ala 
                165                 170                 175     


Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys Ser His Arg Ser 
            180                 185                 190         


Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val Glu Lys Thr Val 
        195                 200                 205             


Ala Pro Thr Glu Cys Ser 
    210                 


